Literature DB >> 12509640

Successful treatment of systemic sclerosis digital ulcers and pulmonary arterial hypertension with endothelin receptor antagonist bosentan.

M Humbert, J Cabane.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12509640     DOI： 10.1093/rheumatology/keg050

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  11 in total

1.  Connective tissue diseases: Treatment of digital ulcers in systemic sclerosis.

Authors:  Sevdalina Lambova; Ulf Müller-Ladner
Journal:  Nat Rev Rheumatol       Date:  2010-11-30       Impact factor: 20.543

Review 2.  Functional autoantibodies in systemic sclerosis.

Authors:  Jeannine Günther; Judith Rademacher; Jakob M van Laar; Elise Siegert; Gabriela Riemekasten
Journal:  Semin Immunopathol       Date:  2015-08-21       Impact factor: 9.623

Review 3.  Recent advances in the treatment of systemic sclerosis.

Authors:  Vasiliki Kalliopi K Bournia; Panayiotis G Vlachoyiannopoulos; Carlo Selmi; Haralampos M Moutsopoulos; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

4.  Is macitentan not a treatment option for digital ulcers in systemic sclerosis?

Authors:  Yoshihide Asano
Journal:  Ann Transl Med       Date:  2016-10

Review 5.  Practical approach to the therapy of systemic sclerosis.

Authors:  L Czirják
Journal:  Z Rheumatol       Date:  2004-12       Impact factor: 1.372

6.  dsRNA activation of endothelin-1 and markers of vascular activation in endothelial cells and fibroblasts.

Authors:  Giuseppina Farina; Michael York; Cindy Collins; Robert Lafyatis
Journal:  Ann Rheum Dis       Date:  2010-11-10       Impact factor: 19.103

7.  Promising therapeutic effects of sodium tanshinone IIA sulfonate towards pulmonary arterial hypertension in patients.

Authors:  Jian Wang; Wenju Lu; Wei Wang; Nuofu Zhang; Hua Wu; Chunli Liu; Xiuqing Chen; Yonghua Chen; Yuqin Chen; Qian Jiang; Lei Xu; Lichun Tian; Pixin Ran; Nanshan Zhong
Journal:  J Thorac Dis       Date:  2013-04       Impact factor: 2.895

Review 8.  The endothelin system as a therapeutic target in cardiovascular disease: great expectations or bleak house?

Authors:  N S Kirkby; P W F Hadoke; A J Bagnall; D J Webb
Journal:  Br J Pharmacol       Date:  2007-10-29       Impact factor: 8.739

9.  Effects of bosentan on the skin lesions: an observational study from a single center in Japan.

Authors:  Masanori Funauchi; K Kishimoto; H Shimazu; Y Nagare; S Hino; T Yano; K Kinoshita
Journal:  Rheumatol Int       Date:  2008-11-27       Impact factor: 2.631

10.  Radical oxygen species production induced by advanced oxidation protein products predicts clinical evolution and response to treatment in systemic sclerosis.

Authors:  A Servettaz; P Guilpain; C Goulvestre; C Chéreau; C Hercend; C Nicco; L Guillevin; B Weill; L Mouthon; F Batteux
Journal:  Ann Rheum Dis       Date:  2007-03-15       Impact factor: 19.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.